About BioTeZ
BioTeZ is a company based in Berlin (Germany) founded in 1992 was acquired by BBI Solutions in January 2022. The company has 20 employees as of December 31, 2020. BioTeZ operates in a competitive market with competitors including Abcam, Stem Cell Technologies, GenScript, Sino Biological and Miltenyi Biotec, among others.
- Headquarter Berlin, Germany
- Employees 20 as on 31 Dec, 2020
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biotez Berlin-Buch Gmbh Biochemisch-Technologisches Zentrum
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
20
as on Dec 31, 2020
-
Acquired by
BBI Solutions
(Jan 04, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of BioTeZ
Investors in BioTeZ
BioTeZ has secured backing from 1 investor. Prominent investors backing the company include BBI Solutions.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Kits and reagents are developed for life science research applications.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BioTeZ
Financial Statements - BioTeZ
Biotez Comparisons
Competitors of BioTeZ
BioTeZ operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, GenScript, Sino Biological and Miltenyi Biotec, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biological reagents and antibodies are developed for life science research.
|
|
| domain | founded_year | HQ Location |
Developer of cell culture media and ancillary reagents for life science research
|
|
| domain | founded_year | HQ Location |
Reagents and instruments are provided for life sciences research.
|
|
| domain | founded_year | HQ Location |
Reagents and kits are provided for clinical research applications.
|
|
| domain | founded_year | HQ Location |
Develops tools and products for research and clinical application
|
|
| domain | founded_year | HQ Location |
Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders
|
Latest news on Biotez
Frequently Asked Questions about BioTeZ
BioTeZ was founded in 1992.
BioTeZ is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.
Uwe Ahnert is the current CEO of BioTeZ.
As of Dec 31, 2020, the latest employee count at BioTeZ is 20.
BioTeZ was founded in 1992 and is based in Berlin, Germany. Operations are centered in the life sciences sector, where products and services such as DNARNA oligonucleotide development, immunoaffinity columns and gels, ELISA and other assays, labeling kits and services, microplate coating, streptavidin tools, antibodies, proteins, enzymes, and related items are provided to support biotechnology research and applications.
BioTeZ's top competitors include Abcam, Sino Biological and Meridian Bioscience.
BioTeZ has 1 investor. Key investors include BBI Solutions.